Ian Kerridge

10.0k total citations
429 papers, 5.6k citations indexed

About

Ian Kerridge is a scholar working on Public Health, Environmental and Occupational Health, General Health Professions and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Ian Kerridge has authored 429 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 166 papers in Public Health, Environmental and Occupational Health, 134 papers in General Health Professions and 67 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Ian Kerridge's work include Ethics in medical practice (79 papers), Biomedical Ethics and Regulation (57 papers) and Palliative Care and End-of-Life Issues (49 papers). Ian Kerridge is often cited by papers focused on Ethics in medical practice (79 papers), Biomedical Ethics and Regulation (57 papers) and Palliative Care and End-of-Life Issues (49 papers). Ian Kerridge collaborates with scholars based in Australia, United States and United Kingdom. Ian Kerridge's co-authors include Wendy Lipworth, Christopher F. C. Jordens, John McPhee, Cameron Stewart, Phyllis Butow, David Henry, Marcus Lowe, Stephanie Johnson, Rachel A. Ankeny and Miles Little and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ian Kerridge

410 papers receiving 5.3k citations

Peers

Countries citing papers authored by Ian Kerridge

Since Specialization

Citations

This map shows the geographic impact of Ian Kerridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Kerridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Kerridge more than expected).

Fields of papers citing papers by Ian Kerridge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Kerridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Kerridge. The network helps show where Ian Kerridge may publish in the future.

Co-authorship network of co-authors of Ian Kerridge

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Kerridge. A scholar is included among the top collaborators of Ian Kerridge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Kerridge. Ian Kerridge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Multidisciplinary Model for the Governance of Clinical Innovation: Insights From a Qualitative Study of Australian Doctors 2025 ·Evaluation & the Health Professions ·(unknown), Ian Kerridge, Wendy Lipworth	0
2	Understanding the Artificial Intelligence Revolution and its Ethical Implications 2025 ·Journal of Bioethical Inquiry ·Amin Beheshti, Ian Kerridge	0
3	Money matters: a critique of ‘informed financial consent’ 2024 ·Medical Law Review ·(unknown), Ian Kerridge, Cameron Stewart, Isabel Karpin, (unknown), Robert J. Norman, Wendy Lipworth	1
4	Diagnosis and management of endothelial disorders following haematopoietic stem cell transplantation 2023 ·Internal Medicine Journal ·Ashley McEwan, Matthew Greenwood, Christopher Wård, David Ritchie, Jeff Szer, Elizabeth E. Gardiner, (unknown), (unknown), (unknown), Ian Kerridge	5
5	The Fragility of Scientific Rigour and Integrity in “Sped up Science”: Research Misconduct, Bias, and Hype and in the COVID-19 Pandemic 2023 ·Journal of Bioethical Inquiry ·Wendy Lipworth, Ian Kerridge, Cameron Stewart, Diego Augusto Santos Silva, Ross Upshur	3
6	Therapeutic misunderstandings in modern research 2023 ·Bioethics ·(unknown), Wendy Lipworth, Sue‐Anne McLachlan, Jennifer Philip, Thomas John, Ian Kerridge	1
7	Multiple COVID-19 vaccine doses in CLL and MBL improve immune responses with progressive and high seroconversion 2022 ·Blood ·Yandong Shen, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ian Kerridge, (unknown), Anouschka Akerman, Anupriya Aggarwal, Vanessa Milogiannakis, (unknown), (unknown), Kerrie J. Sandgren, Stuart Turville, Anthony L. Cunningham, Stephen P. Mulligan	17
8	COVID‐19 vaccine failure in chronic lymphocytic leukaemia and monoclonal B‐lymphocytosis; humoural and cellular immunity 2021 ·British Journal of Haematology ·Yandong Shen, (unknown), (unknown), (unknown), (unknown), Asha Soosapilla, (unknown), Catherine Tang, Ian Kerridge, (unknown), (unknown), Vanessa Milogiannakis, Anouschka Akerman, (unknown), Kerrie J. Sandgren, Anthony L. Cunningham, Stuart Turville, Stephen P. Mulligan	30
9	SUBA-Itraconazole for Primary Antifungal Prophylaxis After Allogeneic Hematopoietic Cell Transplantation 2021 ·Open Forum Infectious Diseases ·Julian Lindsay, Jad Othman, (unknown), (unknown), Sebastiaan J. van Hal, Stephen Larsen, Christian Bryant, John Gibson, Ian Kerridge, Keith Fay, William Stevenson, Chris Arthur, Sharon C.-A. Chen, David C. M. Kong, Matthew Greenwood, Steven A. Pergam, Catherine Liu, Monica A. Slavin	11
10	Cytomegalovirus (CMV) management in allogeneic hematopoietic cell transplantation: Pre‐transplant predictors of survival, reactivation, and spontaneous clearance 2020 ·Transplant Infectious Disease ·Julian Lindsay, Jad Othman, Ian Kerridge, Keith Fay, William Stevenson, Chris Arthur, Sharon C.‐A. Chen, David C. M. Kong, Steven A. Pergam, Catherine Liu, Monica A. Slavin, Matthew Greenwood	8
11	Are my religious beliefs anyone’s business? A framework for declarations in health and biomedicine 2020 ·Journal of Medical Ethics ·Narcyz Ghinea, (unknown), Ian Kerridge, Wendy Lipworth	2
12	A survey of Australian public attitudes towards funding of high cost cancer medicines 2020 ·Health Policy ·Narcyz Ghinea, Christine Critchley, (unknown), Ian Kerridge, Terence J. Campbell, Richard O. Day, Madlen Gazarian, David Isaacs, Winston Liauw, Ian Olver, (unknown), Sallie‐Anne Pearson, Glenn Salkeld, Wendy Lipworth	4
13	Clearing the air: towards agreement about access to high cost cancer medicines 2018 ·Annals of Oncology ·Wendy Lipworth, Ian Kerridge, Narcyz Ghinea, John Zalcberg	2
14	Serum levels, safety and tolerability of new formulation SUBA-itraconazole prophylaxis in patients with haematological malignancy or undergoing allogeneic stem cell transplantation 2017 ·Journal of Antimicrobial Chemotherapy ·Julian Lindsay, Indy Sandaradura, (unknown), Chris Arthur, William Stevenson, Ian Kerridge, Keith Fay, Luke Coyle, Matthew Greenwood	40
15	Ethics and Epistemology of Big Data 2017 ·Journal of Bioethical Inquiry ·Wendy Lipworth, Paul H. Mason, Ian Kerridge	11
16	Epidemiology of complementary and alternative medicine therapy use in allogeneic hematopoietic stem cell transplant survivorship patients in Australia 2016 ·Cancer Medicine ·Julian Lindsay, (unknown), Nicole Gilroy, Gemma Dyer, (unknown), John J. Moore, Matthew Greenwood, Mark Hertzberg, David Gottlieb, Stephen Larsen, (unknown), (unknown), Gillian Huang, (unknown), Christopher Wård, Ian Kerridge	8
17	Involuntary psychiatric treatment in the community: general practitioners and the implementation of community treatment orders. 2015 ·PubMed ·(unknown), Ian Kerridge, Michael J. Robertson, Philip Boyce, Terry Carney, Alan Rosen, Michelle Cleary, Glenn E. Hunt, Nick O’Connor, Christopher Ryan	5
18	What They Want: Inclusion of Blood and Marrow Transplanation Survivor Preference in the Development of Models of Care for Long-Term Health in Sydney, Australia 2015 ·Biology of Blood and Marrow Transplantation ·Gemma Dyer, Nicole Gilroy, (unknown), (unknown), (unknown), (unknown), Matthew Greenwood, Stephen Larsen, John J. Moore, Mark Hertzberg, John Kwan, Gillian Huang, (unknown), Christopher Wård, Ian Kerridge	21
19	Independent therapeutic advice: How achievable is it? 2013 ·The Sydney eScholarship Repository (The University of Sydney) ·(unknown), Paul A. Komesaroff, Ian Kerridge, (unknown)	2
20	Beyond Rhetoric in Debates About the Ethics of Marketing Prescription Medicines to Consumers: The Importance of Vulnerability in People, Situations, and Relationships 2010 ·Research Online (University of Wollongong) ·Stacy M. Carter, Gabrielle Samuel, Ian Kerridge, Richard O. Day, Rachel A. Ankeny, Christopher F. C. Jordens, Paul A. Komesaroff	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact